22947-1-AP

antibody from Proteintech Group

Targeting: BCL9

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

22947-1-AP

Provider

Proteintech Group

Product name

BCL9 antibody

Antibody type

Polyclonal

Description

BCL9 antibody (Cat. #22947-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation.

Wu SY, Zhu YY, Sun JL, Wang CY, Wang YL, Nie YY, Song F, Huang X, Chen Z, He T, Shen LA, Xu Y, Huang C, Qiu SJ, Zhou J, Zhu AX, Fan J, Zhu D, Hu B, Yang XR
Nature communications 2025 Nov 17;16(1):10039

---

Discovery of 2-(isoxazol-5-yl)phenyl 3,4-dihydroxybenzoate as a potential inhibitor for the Wnt/β-catenin pathway.

Dong Y, Liu M, Mao Y, Wu S, Wen J, Lu J, Yang Y, Ruan S, Li L, Liu X, Zhang J, Liao S, Dong L
Bioorganic chemistry 2022 Nov;128:106116

---

Exosomal AFAP1-AS1 binds to microRNA-15a-5p to promote the proliferation, migration, and invasion of ectopic endometrial stromal cells in endometriosis.

Wang X, Zhang M, Jiang L, Fang X, Zhang T
Reproductive biology and endocrinology : RB&E 2022 May 5;20(1):77

---

USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.

Shang Z, Zhao J, Zhang Q, Cao C, Tian S, Zhang K, Liu L, Shi L, Yu N, Yang S
The Journal of biological chemistry 2019 Jun 21;294(25):9844-9857